NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIEHS E-255-2007-0-PCT-02 Detecting And Controlling Abnormal Hematopoiesis PCT PCT PCT/US08/68900 Expired
NCI E-228-2003-1-US-07 SOLUBLE FRAGMENTS OF THE SARS-COV SPIKE GLYCOPROTEIN US National Stage 12/087,306 Abandoned
NIEHS E-255-2007-0-JP-04 Detecting And Controlling Abnormal Hematopoiesis JP National Stage 515237/2010 Abandoned
NIEHS E-255-2007-0-EP-03 Detecting And Controlling Abnormal Hematopoiesis EP National Stage 08781229.3 Abandoned
NIAID E-120-2001-0-IN-09 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses IN DIV 165/DELNP/2008 Abandoned
NIAID E-115-2007-0-US-01 Recombinant Human Parainfluenza Type 1 Viruses (HPIV1S) Containing Mutations in or Deletion of the C Protein Are Attenuated in African Green Monkeys and in Ciliated Human Aireway Epithelial Cells and are Potential Vaccine Candidates for HIPIV1 US ORD 61/077,483 Abandoned
NCI E-060-2000-1-JP-09 SFRP AND PEPTIDE MOTIFS THAT INTERACT WITH SFRP AND METHODS OF THEIR USE JP DIV 2008-169716 Expired
NIA E-032-2009-0-US-01 Serum Carboxymethyl-lysine And Circulating Receptor For Advanced Glycation End Products (RAGE) Es Clinical Biomarkers For Adverse Aging-related Outcomes US 61/133,510 Abandoned
NCI E-141-2008-0-EP-15 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof EP DIV 13195499.2 Issued
NCI E-141-2008-0-IL-04 COMPLEXES OF IL-15 AND IL-15RALPHA AND USES THEREOF IL National Stage 202997 Issued
NCI E-141-2008-0-CA-10 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof CA National Stage 2691785 Issued
NCI E-141-2008-0-HK-08 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof HK National Stage 10109712.6 Issued
NCI E-141-2008-0-AU-09 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof AU National Stage 2008269032 Issued
NCI E-141-2008-0-IE-25 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof IE EP 08779855.9 Issued
NCI E-141-2008-0-IT-19 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof IT EP 08779855.9 Issued
NCI E-141-2008-0-NL-20 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof NL EP 08779855.9 Issued
NCI E-141-2008-0-DK-17 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof DK EP 08779855.9 Issued
NCI E-141-2008-0-DE-22 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof DE EP 08779855.9 Issued
NCI E-141-2008-0-FR-23 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof FR EP 08779855.9 Issued
NCI E-141-2008-0-EP-03 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof EP National Stage 08779855.9 Issued
NCI E-141-2008-0-GB-24 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof GB EP 08779855.9 Issued
NCI E-141-2008-0-SE-21 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof SE EP 08779855.9 Issued
NCI E-141-2008-0-ES-18 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof ES EP 08779855.9 Issued
NCI E-141-2008-0-PCT-02 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof PCT PCT PCT/US2008/008084 Expired
NINDS E-073-1999-0-US-06 RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-XL FUSION PROTEIN INHIBITS APOPTOSIS US DIV 12/147,924 Abandoned
NCI E-141-2008-0-EP-14 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof EP DIV 13195495.0 Abandoned
NICHD E-206-2007-0-EP-05 SUBSTRATE REDUCTION THERAPY EP National Stage 08762509.1 Issued
NICHD E-206-2007-0-ES-15 SUBSTRATE REDUCTION THERAPY ES EP 08762509.1 Issued
NICHD E-206-2007-0-RO-23 SUBSTRATE REDUCTION THERAPY RO EP 08762509.1 Issued
NICHD E-206-2007-0-PL-21 SUBSTRATE REDUCTION THERAPY PL EP 08762509.1 Issued
NICHD E-206-2007-0-SE-24 SUBSTRATE REDUCTION THERAPY SE EP 08762509.1 Issued
NICHD E-206-2007-0-PT-22 SUBSTRATE REDUCTION THERAPY PT EP 08762509.1 Issued
NICHD E-206-2007-0-BE-11 SUBSTRATE REDUCTION THERAPY BE EP 08762509.1 Issued
NICHD E-206-2007-0-CZ-13 SUBSTRATE REDUCTION THERAPY CZ EP 08762509.1 Issued
NICHD E-206-2007-0-NL-20 SUBSTRATE REDUCTION THERAPY NL EP 08762509.1 Issued
NICHD E-206-2007-0-IE-18 SUBSTRATE REDUCTION THERAPY IE EP 08762509.1 Issued
NICHD E-206-2007-0-IT-19 SUBSTRATE REDUCTION THERAPY IT EP 08762509.1 Issued
NICHD E-206-2007-0-FR-16 SUBSTRATE REDUCTION THERAPY FR EP 08762509.1 Issued
NICHD E-206-2007-0-DE-14 SUBSTRATE REDUCTION THERAPY DE EP 08762509.1 Issued
NICHD E-206-2007-0-CH-12 SUBSTRATE REDUCTION THERAPY CH EP 08762509.1 Issued
NICHD E-206-2007-0-GB-17 SUBSTRATE REDUCTION THERAPY GB EP 08762509.1 Issued
NICHD E-206-2007-0-CA-04 Substrate Reduction Therapy CA National Stage 2691937 Issued
NICHD E-206-2007-0-AU-03 Substrate Reduction Therapy AU National Stage 2008269585 Issued
NIDCR E-015-2002-1-US-05 Mammalians Sweet Taste receptors US CON 12/147,415 7977060 Expired PDF
NICHD E-206-2007-0-PCT-02 Treatment Of Smith-Lemli-Opitz Syndrome (SLOS) PCT PCT PCT/GB2008/002207 Expired
NIDDK E-218-2007-2-PCT-01 A2 Adenosine Receptor Agonists PCT PCT COMB PCT/US2008/67978 Abandoned
NIAID E-243-2006-2-JP-05 Nitroimidadzole Analogs With Improved TB Activity JP National Stage 2008547540 Abandoned
CC E-147-2008-0-US-01 Tumor Targeted Thermally Sensitive Liposomes US 61/074,864 Abandoned
NIDDK E-219-2007-2-AU-04 Dendrimer Conjugates Of Agonists And Antagonists Of The GPCR Superfamily AU National Stage 2008270735 Abandoned
NIDDK E-219-2007-2-US-02 Dendrimer Conjugates Of Agonists And Antagonists Of The GPCR Superfamily US ORD 12/143,451 8153781 Abandoned PDF